Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Infect Genet Evol ; 18: 113-24, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23684629

RESUMO

Chikungunya virus (CHIKV) infection has caught attention yet again as it rages around the globe affecting millions of people. The virus caused epidemic outbreaks affecting more than 15,000 people in Odisha, Eastern India since 2010. In this study, complete genetic characterization of E2 gene of CHIKV circulating in Odisha from 2010 to 2011 was performed by virus isolation, RT-PCR, molecular phylogenetics and bioinformatics methods. Phylogenetic analyses revealed the circulation of Indian Ocean Lineage (IOL) strains of ECSA genotype of CHIKV in Odisha. Several mutations were detected in the E2 gene, viz. E2-R82G, E2-L210Q, E2-I211T, E2-V229I and E2-S375T which had various adaptive roles during the evolution of CHIKV. The CHIKV E2 peptide 57KTDDSHD6³ was predicted to be the most probable T-cell epitope and peptide 84FVRTSAPCT9² predicted to be the common T and B cell epitope having high antigenicity. The amino acid positions 356-379 and 365-385 were predicted to be transmembrane helical domains and indicated E2 protein anchorage in intracellular membranes for effective interaction with the host receptors. Positive selection pressure was observed in five specific sites, 210, 211, 318, 375, and 377 which were observed to be fixed advantageously in most viral isolates. Structural modeling revealed that E2 gene of CHIKV was composed of 3 domains and the major adaptive mutations were detected in domain B, which can modulate binding of CHIKV to host cells, while the transmembrane domain in domain C and the epitopes were located in domain A, which was found to be most conserved. This is the first report from Eastern India demonstrating a predictive approach to the genetic variations, epitopic regions and the transmembrane helices of the E2 region. The results of this study, combined with other published observations, will expand our knowledge about the E2 region of CHIKV which can be exploited to develop control measures against CHIKV.


Assuntos
Infecções por Alphavirus/virologia , Vírus Chikungunya/genética , Proteínas do Envelope Viral/genética , Sequência de Aminoácidos , Substituição de Aminoácidos , Febre de Chikungunya , Vírus Chikungunya/classificação , Epitopos de Linfócito B/genética , Epitopos de Linfócito T/genética , Humanos , Índia , Modelos Moleculares , Epidemiologia Molecular , Dados de Sequência Molecular , Filogenia , Seleção Genética , Viremia/virologia
2.
Acta Pharm ; 59(2): 199-210, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19564144

RESUMO

The purpose of the study was to evaluate the suitability of laboratory scale spheronizer for the production of spherical pellets loaded with diltiazem hydrochloride by wax combination. The 1:1 combination of cetyl alcohol and hydrogenated castor oil, as low and high melting point waxes, were used. The various production variables affecting the different characteristics of pellets and the process efficiency were evaluated. Drug loaded pellets were evaluated for drug release in distilled water. Bowl temperature primarily affects the sphericity and adhesion of pellets to the bowl. Mass temperature has a pronounced effect on size, size distribution and sphericity of pellets. Wax concentration affects all characteristics of pellets but adhesion was least affected. The effect of these three variables can be compensated by optimizing the friction plate speed. It has been found that the highest yield of pellets (850--1400 microm) with maximum sphericity can be produced by using 45 degrees C bowl temperature, 52 degrees C mass temperature and 1400 rpm friction plate speed.


Assuntos
Bloqueadores dos Canais de Cálcio/química , Óleo de Rícino/química , Diltiazem/química , Álcoois Graxos/química , Tecnologia Farmacêutica/instrumentação , Ceras/química , Adesividade , Química Farmacêutica , Preparações de Ação Retardada , Estudos de Viabilidade , Fricção , Cinética , Tamanho da Partícula , Solubilidade , Tecnologia Farmacêutica/métodos , Temperatura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA